WASHINGTON, DC—Senators Amy Klobuchar (D-MN) and Mike Lee (R-UT), the Ranking Member and Chairman respectively of the Senate Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights, issued the following statements in response to the announced merger between Walgreens and Rite Aid.
“Competition in the health care industry is essential to keeping health care costs down for American consumers,” Senator Klobuchar said. “I have fought tirelessly to promote competition in the health sector and I believe the proposed merger of two of the three largest drug store chains in the country raises serious issues. It is critical that the proposed Walgreens-Rite Aid merger is closely examined to ensure it does not increase drug prices for consumers or reduce choice for pharmacy services.”
“Our Subcommittee has long been focused on competition in the health care sector,” Senator Lee said. "In December 2011, we held a hearing to examine the competitive effects of the merger between Express Scripts and Medco, two of the largest PBMs. In 2014, we looked at competition in the contact lens market, and last month we held a hearing to discuss the mergers between four of the five largest national health insurers. Competition is essential in every part of our economy, and especially so in a market as complex and important as health care. With that in mind, we hope that the antitrust agencies will closely scrutinize the merger of Walgreens and Rite Aid, the second and third largest drug store chains."